Terminal leukaemia patients who were not responding to treatment now have hope for a cure, thanks to a new experimental pill called revumenib.
This drug has completely eliminated cancer in a third of the participants in a long-awaited clinical trial in the United States.
Although not all patients showed complete remission, scientists remain hopeful as the results indicate that the pill might pave the way to a cure for leukaemia in the future.
New leukimia treatment
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $527.0M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.4¢ | 7.0¢ | $544.4K | 7.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 2027362 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 432108 | 14 |
View Market Depth
| Last trade - 13.05pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.1¢ |
Change
-0.001 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.3¢ | 7.1¢ | 3861244 | ||
| Last updated 13.22pm 15/05/2024 ? | |||||
| IMU (ASX) Chart |